Jordan examines the growing role of direct-to-consumer (DTC) access models in the pharmaceutical sector. He discusses recent regulatory developments, the potential benefits and risks for manufacturers, and key considerations for building sustainable DTC programs.
To learn more, register for AssistRx's October 21st webinar: The New Patient Support Program: Why Regulatory Shifts Require a Higher Caliber of Program Sophistication and How to Do It.
Read on for Jordan’s insights.